RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (2)
Therapeutic options for CTLA-4 insufficiency.
TNFalpha inhibition in MRL/lpr mice ameliorates pulmonary but not renal disease.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TNFalpha inhibition in MRL/lpr mice ameliorates pulmonary but not renal disease.
Kim N, Ussin L, Cheng X, Murali R, Sullivan KE. TNFalpha inhibition in MRL/lpr mice ameliorates pulmonary but not renal disease. J Autoimmun. 2002 Dec; 19(4):215-22.
View in:
PubMed
subject areas
Animals
Antibodies
DNA
Female
Kidney Diseases
Lung Diseases
Lymphocyte Subsets
Mice
Mice, Inbred MRL lpr
Spleen
Tumor Necrosis Factor-alpha
authors with profiles
Kathleen Sullivan, APRN, PMHCNS-BC